An interactive electronic tool that can help reduce deaths to lung cancer
The American Cancer Society has launched a new interactive electronic instrument to help doctors and health workers at the level of US states and local communities design strategies dedicated to reducing lung cancer death rates and improving early detection and treatments. The instrument known as the “planning instrument for state levels” was described in detail in a study periodically published in the scientific “Kanary”. Lung cancer is one of the most important causes of cancer death worldwide, and despite medical progress, early investigative rates are still low, leading to delayed diagnosis, decrease in treatment opportunities and low survival rates. Therefore; The American Cancer Society founded the ‘National Round Cancer Cancer’ in 2017 as a platform that brings together more than 200 public and private sectors and non -profit organizations, including medical institutions, universities, research centers and government agencies, with the aim of uniting efforts to reduce the deaths of the disease. Within this initiative, the working group dealing with US state -level initiatives has accepted the task of developing the electronic tool to meet each state or region a dedicated resource plan that takes into account the real needs, depending on factors such as available financing, health policies, the level of participation of medical service providers and community vision. The tool was developed by meetings, interviews and use tests, with an extensive overview of the content and website design every two weeks, in addition to collecting user opinions through surveys. The facade of the instrument enables the user to target the appropriate recommendations for the nature of the challenges in his region, whether it is related to infrastructure, health culture or human resources. The researchers believe that one of the most important axes of the instrument is to ensure equality in obtaining services, as the scientific team was eager to focus on areas with better resources and neglect the underprivileged societies to expand the geographical, demographic and cultural gaps in the results of lung cancer. The lead author of the study, Robert Smith, said: “It is always said that all public health is locally, and our goal is to provide local leaders, health specialists and activists with instruments that enable them to design effective and dedicated programs to improve lung cancer control in their states.” He added: “Among the many achievements of the national table, the development of this tool remains at the front of the list.” The data from the World Health Organization indicate that lung cancer is killing more than 1.8 million people annually, which is the deadliest types of cancer. Despite the effectiveness of low -dose tomography examination in reducing deaths, rates acceptance is still low, even in countries with advanced health systems. Challenges include lack of awareness, economic barriers and inequality in the spread of resources between regions. Basic facts about lung cancer lung cancer are a kind of cancer that starts when the cells become abnormal and unfair in the lungs. Its common symptoms include: persistent cough, chest pain and shortness of breath. Initial symptoms can be soft, leading to delayed diagnosis. Lung cancer is divided into two main types: NSCLC lung cancer, which is the most common and slow growing, and a small cell song cancer (SCLC) is less common, but grows rapidly. Smoking is the most important risk factor, but there are other factors such as negative smoking, professional exposure to dangerous materials (such as asbestos and radio), and air pollution. Lung cancer is the leading cause of cancer -related death, which includes men and women. Smoking is the main cause of lung cancer, which causes about 85% of all cases. Lung cancer is often diagnosed in advanced stages, where treatment options are limited. Investigation of individuals who are most at risk makes it possible to detect the disease early, which significantly improves survival rates. Initial prevention, such as tobacco control measures, reduces exposure to environmental risks, contributes to reducing lung cancer and saving lives. The best way to prevent disease is not smoking. Other preliminary preventative procedures include avoiding negative smoking, air pollution and reducing professional risks. In terms of secondary prevention, it is performed by examining the most vulnerable individuals with the help of low -doses -to -to. LDCT -Diagnosis: Diagnosis includes physical examination, medical imaging (X -Rays, CT scans), takes a sample tissue (biopsy) to determine the type of cancer, in addition to molecular tests to determine the best treatment options. Treatment: Depends on the type of cancer, the stage and the medical history of the patient. Treatments include: surgery, radiotherapy, chemotherapy, directed therapy and immunotherapy. Locally directed initiatives, such as the new planning tool, are an increasing tendency in public health to link decisions to field reality rather than relying on the United States at the state level. The researchers say that the new instrument can form a turning point in the struggle to combat lung cancer as it combines accurate data with allotted field planning and puts health justice at the center of its strategy; If it manages to increase the investigation rate and expand early treatment, it can contribute to a concrete reduction in the deaths of this disease, which still leads the list of the deadliest cancer around the world.